HomeHealth

Health

Atossa Therapeutics Announces the Appointment of Eric Van Zanten as Vice President, Investor and Public Relations

Atossa Therapeutics Announces the Appointment of Eric Van Zanten as Vice President, Investor and Public Relations

December 8, 2022

BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report

BD Releases 2022 Global Inclusion, Diversity and Equity Annual Report

December 8, 2022

USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI® To Treat Moderate to Severe Gastroparesis

USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI® To Treat Moderate to Severe Gastroparesis

December 8, 2022

GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors

GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors

December 8, 2022

SunStream Bancorp Provides Senior Bridge Financing to Parallel

SunStream Bancorp Provides Senior Bridge Financing to Parallel

December 8, 2022

Spectrum Deadline Alert

Spectrum Deadline Alert

December 8, 2022

Trevena Announces Poster Presentations of TRV045 Nonclinical Epilepsy Data, and OLINVYK Clinical Neurocognitive and GI Data, at Recent Medical Meetings

Trevena Announces Poster Presentations of TRV045 Nonclinical Epilepsy Data, and OLINVYK Clinical Neurocognitive and GI Data, at Recent Medical Meetings

December 8, 2022

BD Named in top 25% of Newsweek’s 2023 List of America’s Most Responsible Companies

BD Named in top 25% of Newsweek’s 2023 List of America’s Most Responsible Companies

December 8, 2022

Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in Metastatic Breast Cancer

Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in Metastatic Breast Cancer

December 8, 2022

Jushi Holdings Inc. Announces Closing of US$69 Million Debt Financing

Jushi Holdings Inc. Announces Closing of US$69 Million Debt Financing

December 8, 2022

« 1 … 79 80 81 82 83 … 128 »